Early test for new obesity injection checks Body's reaction
NCT ID NCT07338214
Summary
This early-stage study is testing a potential weight management drug called petrelintide. It aims to see if using different concentrations of the same single injection dose changes how the body absorbs and handles the drug, and if it affects safety. The study involves 48 adults with a body mass index (BMI) of 27 or higher.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité Research Organisation GmbH
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.